GVA - Granite Construction Inc Stock Price, Fair Value and News

VLON is the stock ticker symbol of Vallon Pharmaceuticals, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Oct 17 2025, market cap of Vallon Pharmaceuticals, Inc. is 4.88 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check VLON's fair value in chart for subscribers.

The fair value guage provides a quick view whether VLON is over valued or under valued. Whether Vallon Pharmaceuticals, Inc. is cheap or expensive depends on the assumptions which impact Vallon Pharmaceuticals, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VLON.

As of Fri Oct 17 2025, VLON's PE ratio (Price to Earnings) is -0.49 and Price to Sales (PS) ratio is 32.7. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VLON PE ratio will change depending on the future growth rate expectations of investors.